PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022

Corporate Breaking News

Home : PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022

Sep 12 2013	PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
NEW YORK, Sept. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to...


Source:http://www.prnewswire.com/news-releases/pharmapoint-dry-eye-syndrome---china-drug-forecast-and-market-analysis-to-2022-223443241.html

Related News
» Best-In-Class Companies Recognized by Frost & Sullivan for Growth, Innovation & Leadership » Alderon Announces Signing of Project Financing Engagement Letter